Outsourcing provides the small pharmaceutical company the ability to take new drugs through clinical trials by avoid the investment in infrastructure which would normally be necessary. This leverage of capital can propel the drug through later stages of clinical development which should lead to more valuable partnerships with large pharmaceutical companies due to the increased value demonstrated in the clinic